New study: Promising breakthrough in slowing the progression of ALS
Data demonstrates halting of disease progression in patients with ALS at 24 weeks.
Stay updated with breaking news from Stanley Appel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data demonstrates halting of disease progression in patients with ALS at 24 weeks.
This investigator-initiated, double-blind, placebo-controlled study evaluates the safety and tolerability, biological activity, and preliminary efficacy of LD IL-2 in 38 patients with...
06/05/1976 (Season 1976): With Abba, Cliff Richard, Robin Sarstedt and Ruby Flipper. TOTP: 1976 airs on BBC Four HD at 8:30 PM, Friday 3 May. With Abba, Cliff Richard, Robin Sarstedt and Ruby Flipper
Serum 4-Hydroxynonenal levels are significantly increased in ALS patients- the higher the 4-HNE level, the faster the progression and shorter the survival; Serum 4-HNE levels are increased in...
4-Hydroxynonenal levels strongly correlate with rate of Amyotrophic Lateral Sclerosis disease progression and survival of patients from onset and diagnosis to death 4-HNE levels may serve as a...